EV/EBITDA:
10.08+0.06(+0.60%)Summary
- As of today, HALO EV/EBITDA is 10.08, with a rise of +0.06 (+0.60%) during the most recent trading session on December 5, 2025.
- Over the past year, HALO EV/EBITDA has dropped by -1.90 (-15.86%).
- HALO EV/EBITDA is now -99.68% below its all-time high of 3171.43.
Performance
HALO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
HALO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +0.6% | +0.5% | +0.6% |
| 1M1 Month | -6.6% | -6.6% | -7.3% |
| 3M3 Months | -17.9% | -15.1% | -15.5% |
| 6M6 Months | -3.5% | +12.2% | +18.3% |
| YTDYTD | -3.1% | +20.9% | +32.5% |
| 1Y1 Year | -15.9% | +18.8% | +31.8% |
| 5Y5 Years | -91.9% | +50.9% | +57.9% |
HALO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 11.61 | -13.2% | 10.02 | +0.6% |
| 3M | 3-Month | 12.78 | -21.1% | 10.02 | +0.6% |
| 6M | 6-Month | 12.78 | -21.1% | 8.94 | +12.8% |
| 1Y | 1-Year | 13.69 | -26.4% | 8.94 | +12.8% |
| 3Y | 3-Year | 31.68 | -68.2% | 8.94 | +12.8% |
| 5Y | 5-Year | 134.51 | -92.5% | 8.94 | +12.8% |
| All-Time | All-Time | 3171.43 | -99.7% | -205.45 | +104.9% |
HALO EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 10.08(-3.1%) |
| 2024 | 10.40(-19.6%) |
| 2023 | 12.94(-53.8%) |
| 2022 | 28.00(+28.0%) |
| 2021 | 21.87(-42.3%) |
| 2020 | 37.89(+189.1%) |
| 2019 | -42.53(-33.7%) |
| 2018 | -31.82(-203.9%) |
| 2017 | 30.62(+288.4%) |
| 2016 | -16.25(+80.9%) |
| Date | Value |
|---|---|
| 2015 | -85.29(-361.8%) |
| 2014 | -18.47(+13.9%) |
| 2013 | -21.46(-63.8%) |
| 2012 | -13.10(+73.9%) |
| 2011 | -50.13(-270.8%) |
| 2010 | -13.52(-70.3%) |
| 2008 | -7.94(+52.0%) |
| 2007 | -16.55(+50.1%) |
| 2006 | -33.19(-389.5%) |
| 2005 | -6.78 |
FAQ
- What is Halozyme Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Halozyme Therapeutics, Inc.?
- What is HALO EV/EBITDA year-to-date change?
- What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Halozyme Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of HALO is 10.08
What is the all-time high EV/EBITDA for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high EV/EBITDA is 3171.43
What is HALO EV/EBITDA year-to-date change?
Halozyme Therapeutics, Inc. EV/EBITDA has changed by -0.32 (-3.08%) since the beginning of the year
What is Halozyme Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, HALO EV/EBITDA has changed by -1.90 (-15.86%)